Here, we performed a series of cell biological and oncology-related experiments to identify the mechanism underlying GC liver metastasis and identified GFRA1 as being a reliable biomarker and potential therapeutic target for GC patients with liver metastasis. Here, GFRA1 is linked to gastric cancer.